Sort   by:  
 Page size 
UnknownCHANGES IN DIABETIC RETINOPATHY SEVERITY WHEN TREATING DIABETIC MACULAR EDEMA WITH RANIBIZUMAB: DRCR.net Protocol I 5-Year Report.
Not available
S-EPMC6547828 | biostudies-literature
UnknownDIPG-52. PHASE I CLINICAL TRIAL OF ONC201 IN PEDIATRIC H3 K27M-MUTANT GLIOMA OR NEWLY DIAGNOSED DIPG
Not available
S-EPMC7715960 | biostudies-literature
UnknownPhase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy.
Not available
S-EPMC9639395 | biostudies-literature
UnknownNew strains of hepatitis B virus genotype E circulating in Nigeria.
Not available
S-EPMC6257873 | biostudies-literature
UnknownDNA Methylation and Histone Modification in Low-Grade Gliomas: Current Understanding and Potential Clinical Targets.
Not available
S-EPMC9954183 | biostudies-literature
UnknownMalignant glioma subset from actuate 1801: Phase I/II study of 9-ING-41, GSK-3β inhibitor, monotherapy or combined with chemotherapy for refractory malignancies.
Not available
S-EPMC8989389 | biostudies-literature
UnknownAssociation Between Change in Visual Acuity and Change in Central Subfield Thickness During Treatment of Diabetic Macular Edema in Participants Randomized to Aflibercept, Bevacizumab, or Ranibizumab: A Post Hoc Analysis of the Protocol T Randomized Clinical Trial.
Not available
S-EPMC6604439 | biostudies-literature
UnknownMetagenomic surveillance uncovers diverse and novel viral taxa in febrile patients from Nigeria.
Not available
S-EPMC10403498 | biostudies-literature
UnknownFactors Associated With Visual Acuity and Central Subfield Thickness Changes When Treating Diabetic Macular Edema With Anti-Vascular Endothelial Growth Factor Therapy: An Exploratory Analysis of the Protocol T Randomized Clinical Trial.
Not available
S-EPMC6459102 | biostudies-literature
UnknownBiological activity of weekly ONC201 in adult recurrent glioblastoma patients.
Not available
S-EPMC7080220 | biostudies-literature
Sort   by:  
 Page size